Robert Svatek, MD,MS

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Ferring Pharmaceuticals
    Date added:
    Date updated:
    01/23/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Cold Genesys
    Date added:
    Date updated:
    01/23/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Rapamycin Holdings
    Date added:
    Date updated:
    01/23/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Ferring Pharmaceuticals
    Date added:
    Date updated:
    01/23/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Cold Genesys
    Date added:
    Date updated:
    01/23/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Rapamycin Holdings
    Date added:
    Date updated:
    01/23/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Ferring Pharmaceuticals
    Date added:
    Date updated:
    01/23/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Cold Genesys
    Date added:
    Date updated:
    01/23/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Rapamycin Holdings
    Date added:
    Date updated:
    01/23/2023
Return to The Role of Immune Checkpoint Inhibitors in Bladder Cancer Podcast (2019)